Safety and Immunogenicity of Coadministration of the Candidate Rabies Vaccine ChAdOx2 RabG and Licensed Vaccine

Inclusion Criteria: * Healthy male or female adults aged 18-45 years at the time of enrolment with signed consent. * (Female only participants): Must be non-pregnant (as demonstrated by a negative serum pregnancy test) and willing to use an effective form of contraception. \*Female volunteers are required to use an effective form of contraception during the course of the study. There is currently no information about the effect of this vaccine on a foetus. Acceptable forms of contraception for female volunteers include: * Established use of injected or implanted hormonal methods of contraception. * Placement of an intrauterine device (IUD) or intrauterine system (IUS). * Total abdominal hysterectomy. * Planned long-term (at least 2 months from the date of the first vaccination) or permanent residence in Bagamoyo town. * Adults with a Body Mass Index (BMI) 18 to 30 Kg/m2 * Correctly answer all 10 questions on the protocol and study procedures understanding questionnaire within 2 attempts. Exclusion Criteria: * Clinically significant congenital abnormalities as judged by the PI or other delegated individual. * Clinically significant history of skin disorder, allergy, cardiovascular disease, respiratory disease, endocrine disorder, liver disease, renal disease, gastrointestinal disease and neurological illness which may significantly increase the risk to the volunteer because of participation in the study, affect the ability of the volunteer to participate in the study or …